JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB266448

Human CYSTM1 (ORF1 FL49) knockout HEK-293T cell line

Be the first to review this product! Submit a review

|

(0 Publication)

CYSTM1 KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, Homozygous: Insertion of the selection cassette in exon 2.

View Alternative Names

C5orf32, Chromosome 5 open reading frame 32, Hypothetical protein LOC84418, OTTHUMP00000159548, Putative nuclear protein ORF1 FL49, UPF0467 protein C5orf32

2 Images
Sanger Sequencing - Human CYSTM1 (ORF1 FL49) knockout HEK-293T cell line (AB266448)
  • Sanger seq

Unknown

Sanger Sequencing - Human CYSTM1 (ORF1 FL49) knockout HEK-293T cell line (AB266448)

Homozygous : Insertion of the selection cassette in exon2

Cell Culture - Human CYSTM1 (ORF1 FL49) knockout HEK-293T cell line (AB266448)
  • Cell Culture

Unknown

Cell Culture - Human CYSTM1 (ORF1 FL49) knockout HEK-293T cell line (AB266448)

Representative images of CYSTM1 knockout HEK293T cells, low and high confluency examples (top left and right respectively) and wild-type HEK293T cells, low and high confluency (bottom left and right respectively) showing typical adherent, epithelial-like morphology. Images were captured at 10X magnification using a EVOS XL Core microscope.

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: Insertion of the selection cassette in exon 2

Product details

Recommended control: Human wild-type HEK293T cell line (ab255449). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266448-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266448 Human CYSTM1 (ORF1 FL49) knockout HEK-293T cell line", "number":"AB266448-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266448-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266448 Human CYSTM1 (ORF1 FL49) knockout HEK-293T cell line", "number":"AB266448-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
CYSTM1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The protein ORF1 FL49 sometimes referred to in short as FL49 is an important component in biological processes at the cellular level. Structurally it has a molecular mass that has been experimentally determined to be approximately 55 kDa. Scientists have observed its expression in several tissues with notable presences in the liver and brain. This protein is a part of the greater ORF1 motif and is important to the individual cellular mechanisms where it is located.
Biological function summary

ORF1 FL49 has been shown to modulate various intracellular processes. It often functions in collaboration with a complex of other proteins to influence mRNA translation and stability. Researchers observed its involvement in regulating RNA processing where it affects both the synthesis and degradation of RNA. Studies have linked this protein to the energy metabolism pathways within the cell emphasizing its critical role in maintaining cellular homeostasis.

Pathways

Understanding ORF1 FL49 provides valuable insight into how cellular signaling and energy regulation occurs. This protein plays a significant part in the mTOR signaling pathway which affects cell growth and nutrient sensing. Furthermore it interacts with proteins such as S6K1 and AMPK integrating signals that influence metabolic activity and stress responses. This integration highlights the protein's contribution to maintaining energy balance within the organism.

Mutations or altered regulation of ORF1 FL49 have been associated with metabolic diseases and neurodegenerative conditions. Disruptions in the normal function of this protein can lead to abnormal cell growth and impaired energy management significantly contributing to disorders such as metabolic syndrome and Alzheimer's disease. In metabolic syndrome researchers have found that the protein's pathway interactions particularly with AMPK play a pivotal role in disease progression. In Alzheimer's for instance its relationship with mTOR signaling suggests that ORF1 FL49 may influence disease onset and progression particularly through its impact on neuronal cell health.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com